These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9138460)

  • 1. Toxoplasmosis in HIV-positive women: seroprevalence and the role of prophylaxis in preventing disease.
    Ruiz R; Cu-Uvin S; Fiore T; Flanigan TP
    AIDS; 1997 Jan; 11(1):119-20. PubMed ID: 9138460
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary prevention of toxoplasmosis in patients with HIV infection].
    Peńa JM; Vázquez JJ
    Med Clin (Barc); 1994 Apr; 102(16):621-3. PubMed ID: 8208039
    [No Abstract]   [Full Text] [Related]  

  • 3. A prospective study of seroprevalence of Toxoplasmosis in general population, and in HIV/AIDS patients in Bombay, India.
    Meisheri YV; Mehta S; Patel U
    J Postgrad Med; 1997; 43(4):93-7. PubMed ID: 10740734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing and management of Toxoplasma serology in HIV-seropositive patients.
    Aarons E; Hawkins D; Nelson M; Gazzard B
    AIDS; 1996 Apr; 10(4):443-4. PubMed ID: 8728051
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the IgG anti-Toxoplasma response and its avidity by western-blot in HIV-patients].
    Cristina Sarmiento M; Gómez Marín JE; Castaño Osorio JC
    Rev Cubana Med Trop; 2005; 57(2):125-32. PubMed ID: 17966582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An audit of the use of prophylaxis against toxoplasmic encephalitis in HIV disease.
    Fox E; Dean G; de Ruiter A
    Int J STD AIDS; 1998 Mar; 9(3):177-9. PubMed ID: 9530907
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyrimethamine as primary prophylaxis of toxoplasmic encephalitis in patients infected with human immunodeficiency virus: open study.
    Bachmeyer C; Gorin I; Deleuze J; Morini JP; Escande JP
    Clin Infect Dis; 1994 Mar; 18(3):479-80. PubMed ID: 8011845
    [No Abstract]   [Full Text] [Related]  

  • 8. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system toxoplasmosis in AIDS.
    Klein RS
    N Engl J Med; 1993 May; 328(18):1352-3; author reply 1354. PubMed ID: 8369035
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxoplasmosis in HIV/AIDS patients: a current situation.
    Nissapatorn V; Lee C; Quek KF; Leong CL; Mahmud R; Abdullah KA
    Jpn J Infect Dis; 2004 Aug; 57(4):160-5. PubMed ID: 15329448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxoplasma serology in HIV infected patients and suspected cerebral toxoplasmosis at the Central Hospital of Bobo-Dioulasso (Burkina Faso)].
    Millogo A; Ki-Zerbo GA; Traoré W; Sawadogo AB; Ouédraogo I; Péghini M
    Bull Soc Pathol Exot; 2000 Feb; 93(1):17-9. PubMed ID: 10774487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system toxoplasmosis in AIDS.
    Bretagne S; Gray F; Costa JM
    N Engl J Med; 1993 May; 328(18):1353-4. PubMed ID: 8469263
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995. HEMOCO and SEROCO Study Groups.
    Belanger F; Derouin F; Grangeot-Keros L; Meyer L
    Clin Infect Dis; 1999 Mar; 28(3):575-81. PubMed ID: 10194081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of specific IgA antibodies in AIDS patients with Toxoplasma infection: a bicentric evaluation.
    Darcy F; Foudrinier F; Mougeot G; Decoster A; Caron A; Marx-Chemla C; Capron A; Pinon JM
    Immunol Lett; 1991 Nov; 30(3):344-7. PubMed ID: 1800320
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxoplasma gondii antibody in HIV-infected persons.
    Sukthana Y; Chintana T; Lekkla A
    J Med Assoc Thai; 2000 Jun; 83(6):681-4. PubMed ID: 10932497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii.
    Zangerle R; Allerberger F
    J Acquir Immune Defic Syndr (1988); 1994 Feb; 7(2):207-8. PubMed ID: 8301536
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxoplasma infection in healthy persons and in patients with HIV or ocular disease.
    Wongkamchai S; Rungpitaransi B; Wongbunnate S; Sittapairochana C
    Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):655-8. PubMed ID: 9139370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention].
    Leport C; Ambroise-Thomas P; Bazin C; Chène G; Derouin F; Katlama C; Mayaud C; Pelloux H; Raffi F; Vildé JL
    Ann Med Interne (Paris); 1996; 147(5):331-2. PubMed ID: 9033735
    [No Abstract]   [Full Text] [Related]  

  • 19. Discontinuation of secondary prophylaxis for toxoplasmic encephalitis in human immunodeficiency virus infection after immune restoration with highly active antiretroviral therapy.
    Guex AC; Radziwill AJ; Bucher HC
    Clin Infect Dis; 2000 Mar; 30(3):602-3. PubMed ID: 10722454
    [No Abstract]   [Full Text] [Related]  

  • 20. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
    Koch A; Kothe H; Braun J; Kämmerer R; Friedrich HJ; Dalhoff K
    Pneumologie; 1998 Nov; 52(11):614-21. PubMed ID: 9885511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.